Ioanna Andreadou Selected Research

Phosphotransferases (Kinase)

1/2021	Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond.
1/2021	Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure.
1/2017	Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
8/2008	Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ioanna Andreadou Research Topics

Disease

30	Infarction (Infarctions) 10/2023 - 10/2002
25	Ischemia 11/2023 - 02/2002
18	Reperfusion Injury 11/2023 - 04/2003
13	Myocardial Infarction 11/2023 - 10/2002
11	Heart Failure 04/2024 - 08/2005
11	Cardiotoxicity 04/2024 - 03/2007
9	Myocardial Ischemia (Ischemic Heart Diseases) 11/2023 - 08/2004
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2006
6	Type 2 Diabetes Mellitus (MODY) 08/2021 - 01/2017
6	Acute Coronary Syndrome 04/2020 - 05/2005
5	Multiple Myeloma 04/2024 - 10/2021
5	Inflammation (Inflammations) 04/2024 - 10/2006
5	Neoplasms (Cancer) 03/2024 - 11/2022
5	Atherosclerosis 07/2023 - 09/2010
4	Body Weight (Weight, Body) 01/2021 - 04/2006
4	Rheumatoid Arthritis 11/2020 - 05/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 07/2014
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2023 - 06/2008
3	Abdominal Aortic Aneurysm 12/2022 - 08/2007
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 03/2015
3	Necrosis 04/2013 - 04/2006
3	Lung Injury 08/2010 - 02/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2024 - 01/2017
2	Anemia 12/2023 - 04/2009
2	Hypertension (High Blood Pressure) 12/2023 - 01/2021
2	Hypoxia (Hypoxemia) 12/2022 - 01/2021
2	COVID-19 11/2021 - 11/2020
2	Cardiomyopathies (Cardiomyopathy) 10/2021 - 04/2014
2	Acute Lung Injury 07/2021 - 06/2008
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2020
2	Disease Progression 10/2017 - 12/2006

Drug/Important Bio-Agent (IBA)

19	AntioxidantsIBA 12/2023 - 02/2002
10	Malondialdehyde (Propanedial)IBA 10/2016 - 02/2002
8	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2007
7	carfilzomibIBA 04/2024 - 01/2019
7	oleuropeinIBA 01/2021 - 08/2006
6	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 04/2003
6	Biomarkers (Surrogate Marker)IBA 08/2021 - 07/2009
6	CholesterolIBA 01/2018 - 08/2006
5	empagliflozinIBA 01/2023 - 01/2017
5	LipidsIBA 12/2020 - 05/2005
4	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2006
4	SodiumIBA 01/2023 - 01/2020
4	3-nitrotyrosineIBA 01/2021 - 03/2010
4	Phosphotransferases (Kinase)IBA 01/2021 - 08/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2007
4	Simendan (Levosimendan)IBA 01/2020 - 08/2005
4	oxidized low density lipoproteinIBA 01/2020 - 03/2010
4	salicylhydroxamic acid (SHAM)IBA 03/2014 - 03/2004
4	MelatoninIBA 04/2013 - 08/2004
3	LDL Lipoproteins (beta Lipoproteins)IBA 07/2023 - 09/2010
3	Proteasome InhibitorsIBA 11/2022 - 01/2019
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022 - 03/2007
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2021 - 06/2012
3	CalciumIBA 01/2021 - 08/2008
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2019 - 05/2008
3	CytokinesIBA 01/2019 - 08/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2017 - 04/2002
3	Interleukin-6 (Interleukin 6)IBA 03/2015 - 08/2005
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2004 - 04/2002
2	Atorvastatin (Lipitor)FDA Link 04/2024 - 03/2024
2	Olive OilIBA 12/2023 - 07/2023
2	Adenosine Triphosphate (ATP)IBA 11/2023 - 08/2008
2	Antineoplastic Agents (Antineoplastics)IBA 09/2023 - 07/2009
2	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 07/2023 - 01/2017
2	Oxygen (Dioxygen)IBA 12/2022 - 01/2021
2	LigandsIBA 11/2022 - 01/2015
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 08/2021 - 01/2020
2	Phospholipases (Phospholipase)IBA 07/2021 - 06/2008
2	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 01/2021 - 04/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	Xanthine OxidaseIBA 01/2021 - 01/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 01/2021
2	WortmanninIBA 01/2021 - 04/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	tocilizumab (atlizumab)FDA Link 11/2020 - 10/2019
2	SmokeIBA 07/2020 - 11/2016
2	InterleukinsIBA 01/2020 - 09/2017
2	Insulin (Novolin)FDA Link 01/2020 - 01/2017
2	LDL CholesterolIBA 01/2020 - 10/2016
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 09/2017
2	Liraglutide FDA Link 01/2020 - 01/2018
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2019 - 07/2014
2	IncretinsIBA 07/2019 - 01/2018
2	Cyclophilins (Cyclophilin)IBA 01/2019 - 01/2016
2	Platelet Activating FactorIBA 01/2019 - 06/2008
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2019 - 08/2008
2	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 03/2010
2	EnzymesIBA 01/2017 - 06/2008
2	ChloridesIBA 10/2016 - 10/2002
2	Interleukin-1 (Interleukin 1)IBA 07/2014 - 05/2008
2	Deferoxamine (Desferal)FDA LinkGeneric 08/2010 - 08/2008
2	IronIBA 08/2010 - 08/2008

Therapy/Procedure

14	Therapeutics 03/2024 - 08/2005
3	Hepatectomy 04/2012 - 02/2010
2	Percutaneous Coronary Intervention 11/2023 - 06/2009
2	Ligation 01/2016 - 09/2004
2	Ovariectomy (Oophorectomy) 04/2013 - 08/2006